Skip to main content
. 2022 May 12;24(1):204. doi: 10.3892/ol.2022.13325

Figure 3.

Figure 3.

Anti-neoplastic activity of metformin via inhibition of AMPK/mTOR pathway. Inhibition of AMPK/mTOR pathway leading to the arrest of protein synthesis is a major anti- neoplastic activity of metformin.